A A A

Current review panels

Review panels are composed for specific competitions and membership will depend on the expertise needed. Please select the appropriate competition for current information on panel composition.

Note:

For competitions with an LOI stage - panels may be reduced between stages depending on expertise required to review the full applications. Panel members participating in the LOI review only will be marked with an *.

For competitions with multiple panels – applicants indicate their panel recommendation, however, final panel selection will be determined by the panel chairs and CCS based on the panel with the most appropriate expertise.

Innovation Grant and Innovation to Impact Grant panels

I1a - Biomarkers and Genomics

Including genomics, proteomics, metabolomics (and other ‘omics’), high-throughput sequencing, bioinformatics, diagnostic, prognostic and predictive biomarkers, circulating tumour cells.

Panel meeting: June 15, 2018

Paul Boutros, PhD (Chair) Ontario Institute for Cancer Research
Toronto, ON
Dwayne Barber, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Tarek Bismar, PhD University of Calgary
Calgary, AB
Nicolas Bisson, PhD Laval University
Quebec City, QC
Susan Done, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Michael Fraser, PhD Ontario Institute for Cancer Research
Toronto, ON
Steven Gallinger, MD Mount Sinai Hospital
Toronto, ON
Robert Gooding, PhD
Queen's University
Kingston, ON
Justin Guinney, PhD Fred Hutchinson Cancer Research Center
Seattle, WA
Cynthia Hawkins, MD/PhD The Hospital for Sick Children
Toronto, ON
Rayjean Hung, PhD Mount Sinai Hospital
Toronto, ON
Philip Kim, PhD
University of Toronto
Toronto, ON
Hon Leong, PhD Mayo Clinic
Rochester, MN
Julian Lum, PhD BC Cancer Agency (Victoria)
Victoria, BC
Mark Minden, MD/PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Leigh Murphy, PhD Cancer Care Manitoba
Winnipeg, MB
Anthony Nichols, MD/PhD Lawson Health Research Institute
London, ON
Torsten Nielsen, MD/PhD University of British Columbia
Vancouver, BC
Jüri Reimand, PhD Ontario Institute for Cancer Research
Toronto, ON
Gelareh Zadeh, MD/PhD Toronto Western Hospital - UHN
Toronto, ON
Michael Downey, PhD (Scientific Officer) University of Ottawa
Ottawa, ON
Katayoon Kasaian, PhD (Scientific Officer) Ontario Institute for Cancer Research
Toronto, ON 
Lee Jones (Community Representative) Canadian Cancer Society - Ontario
Sean Nurmsoo (Community Representative) Canadian Cancer Society - Nova Scotia 

 

I1b - Gene Regulation & Cell Biology

Including mechanisms of transcriptional control, epigenetics, chromatin structure and function, translational control, RNA biology, post-translational modifications, telomere function, DNA damage and repair, organellar biology, model organisms, angiogenesis, cell migration, cell invasion, tumour environment.

Panel meeting: June 27, 2018

Peter Greer, PhD (Chair) Queen's University
Kingston, ON
Christina Addison, PhD Ottawa Hospital Research Institute
Ottawa, ON
David Brindley, PhD University of Alberta
Edmonton,AB
Marc Coppolino, PhD University of Guelph
Guelph, ON
Jacques Drouin, PhD Institut de recherches cliniques de Montréal
Montréal, QC
Sean Egan, PhD The Hospital for Sick Children
Toronto, ON
Marc Ekker, PhD University of Ottawa
Ottawa, ON
Richard Fahlman, PhD
University of Alberta
Edmonton, AB
Vincent Giguere, PhD McGill University
Montreal, QC
Mark Glover, PhD University of Alberta
Edmonton, AB
Ing Swie Goping, PhD University of Alberta
Edmonton, AB
Douglas Gray, PhD Ottawa Hospital Research Institute
Ottawa, ON
Martin Hirst, PhD University of British Columbia
Vancouver, BC
LeAnn Howe, PhD University of British Columbia
Vancouver, BC 
Nagarajan Kannan, PhD Mayo Clinic
Rochester, MN
Aly Karsan, MD BC Cancer Agency
Vancouver, BC
Benjamin Kwok, PhD University of Montreal
Montreal, QC
Dale Laird, PhD Western University
London, ON
Daniel Schramek, PhD Mount Sinai Hospital
Toronto, ON
Carrie Shemanko, PhD University of Calgary
Calgary, AB 
Julie St Pierre, PhD McGill University
Montreal, QC
Franco Vizeacoumar, PhD University of Saskatchewan
Saskatoon, SK
Valerie Wallace, PhD The Toronto Hospital (Western Division)
Toronto, ON
Michael Witcher, PhD McGill University
Montreal, QC
Jason Fish, PhD (Scientific Officer) University Health Network
Toronto, ON
Jim Uniacke, PhD (Scientific Officer) University of Guelph
Guelph, ON
Tanya Gallant (Community Representative) Canadian Cancer Society - PEI
Shayenne Selleck (Community Representative) Canadian Cancer Society - Alberta/NWT 

 

I2 - Imaging and Technology Development

Including platform and tool development, systems biology, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computer tomography (CT), radiobiology, radiotherapy, photodynamic therapy (PDT), optical imaging, microfluidics, nanotechnology.

Panel meeting: June 18, 2018

Brian Wilson, PhD (Chair) Princess Margaret Cancer Centre - UHN
Toronto, ON
Purang Abolmaesumi, PhD University of British Columbia
Vancouver, BC
Ralph DaCosta, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Qiyin Fang, PhD McMaster University
Hamilton, ON
Michael Kolios, PhD Ryerson University
Toronto, ON
Jonathan Lovell, PhD University at Buffalo
Amherst, NY
Noami Matsuura, PhD University of Toronto
Toronto, ON 
Alan Nichol, MD BC Cancer Agency
Vancouver, BC
Brian Nieman, PhD The Hospital for Sick Children
Toronto, ON
Andrew Pelling, PhD University of Ottawa
Ottawa, ON 
Christopher Phenix, PhD University of Saskatchewan
Saskatoon, SK
Aaron Ward, PhD
Western University
London, ON
William Whelan, PhD University of Prince Edward Island
Charlottetown, PE
Roger Zemp, PhD University of Alberta
Edmonton, AB
Gang Zheng, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Katherine Zukotynski, MD McMaster University
Hamilton, ON
Meaghan O'Reilly, PhD (Scientific Officer) Sunnybrook Research Institute
Toronto, ON
Atiya Yahya, PhD (Scientific Officer) Cross Cancer Institute
Edmonton, AB
Sharon Chandler (Community Representative) Canadian Cancer Society - Ontario
Stephen Ng (Community Representative) Canadian Cancer Society - BC/Yukon

 

I3 - Immunology, Signalling and Stem Cells

Including metastasis, hormone-sensitive pathways, growth-factor mediated signalling, immunotherapies, viral therapeutics, cancer stem cells, signal transduction, innate immunity and infection, tumour antigens, immune surveillance, hematopoiesis.

Panel meeting: June 28, 2018

Kevin Kane, PhD (Chair) University of Alberta
Edmonton, AB
Alison Allan, PhD Western University
London, ON
Phedias Diamandis, MD/PhD Toronto General Hospital - UHN
Toronto, ON
David Evans, PhD University of Alberta
Edmonton, AB
Anne-Claude Gingras, PhD Mount Sinai Hospital
Toronto, ON
Michael Gold, PhD University of British Columbia
Vancouver, BC
Kenneth Harder, PhD University of British Columbia
Vancouver, BC
Christina Haston, PhD University of British Columbia
Okanagan, BC
Norman Iscove, MD/PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Sam K.P. Kung, PhD University of Manitoba
Winnipeg, MB
David Litchfield, PhD Western University
London, ON
Luke McCaffrey, PhD McGill University
Montreal, QC
Don Morris, MD/PhD University of Calgary
Calgary, AB
Guy Sauvageau, MD/PhD University of Montreal
Montreal, QC
Matthew Smith, PhD University of Montreal
Montreal, QC
Woong-Kyung Suh, PhD McGill University
Montreal, QC
Michel Tremblay, PhD McGill University
Montreal, QC
Josie Ursini Siegel, PhD Lady Davis Institute
Montreal, QC
John Wilkins, PhD University of Manitoba
Winnipeg, MB
Patrick O'Donoghue, PhD (Scientific Officer) Western University
London, ON
Jean Wang, MD/PhD (Scientific Officer) Princess Margaret Cancer Centre - UHN
Toronto, ON
Sandy McDonald (Community Representative) Canadian Cancer Society - Ontario
Genevieve Roussy (Community Representative) Canadian Cancer Society - New Brunswick

 

I4 - Novel Therapeutics

Including drug candidates, rational drug design, hit and target validation, compound screening, medicinal chemistry, pharmacology, drug delivery systems, drug transport, drug resistance, combination therapies and pharmacogenomics.

Panel meeting: June 21, 2018

Craig Thomas, PhD (Chair) National Institutes of Health (US)
Bethesda, MD
Philippe Bedard, MD
Princess Margaret Cancer Centre - UHN
Toronto, ON 
Robert Britton, PhD
Simon Fraser University
Burnaby, BC
Michele Ceribelli, PhD National Institutes of Health (US)
Bethesda, MD 
Devika Chithrani, PhD University of Victoria
Victoria, BC 
Jason Crawford, PhD University of British Columbia
Vancouver, BC
Daniel De Carvalho, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
James Gleason, PhD McGill University
Montreal, QC
Taran Gujral, PhD Fred Hutchinson Cancer Research Center
Seattle, WA
John Hassell, PhD McMaster University
Hamilton, ON
Robert Korneluk, PhD Children's Hospital of Eastern Ontario
Ottawa, ON
Sylvie Mader, PhD University of Montreal
Montreal, QC
Wilson Miller, MD/PhD Jewish General Hospital
Montreal, QC
Gregg Morin, PhD BC Cancer Agency
Vancouver, BC
Mark Nachtigal, PhD
University of Manitoba
Winnipeg, MB
Lawrence Panasci, PhD Jewish General Hospital
Montreal, QC
Kostas Pantopoulos, PhD Jewish General Hospital
Montreal, QC 
Tom Pfeifer, PhD The Centre for Drug Research and Development
Vancouver, BC
Lynne Postovit, PhD University of Alberta
Edmonton, AB
Brent Rexer, MD/PhD Vanderbilt University
Nashville, TN
Jack Shern, MD National Cancer Institute
Bethesda, MD
Christian Steidl, PhD BC Cancer Agency
Vancouver, BC
Suzanne Trudel, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON 
David Uehling, PhD Ontario Institute for Cancer Research
Toronto, ON
Marielle Yohe, MD/PhD National Cancer Institute
Bethesda, MD
Brita Danielson, MD (Scientific Officer) Cross Cancer Institute (Alberta Health Services)
Edmonton, AB
Christopher Moraes, PhD (Scientific Officer) McGill University
Montreal, QC
Loradonna Botter (Community Representative) Canadian Cancer Society - Alberta/NWT
Diane Hawrylenko (Community Representative) Canadian Cancer Society - Ontario
Anick Labelle (Community Representative) Canadian Cancer Society - Quebec

 

I5 - Prevention and Quality of Life 

Including epidemiology, prevention interventions, lifestyle and environmental risk factors, health economics, health services, quality of life, survivorship, palliative care, psychosocial issues, knowledge translation and exchange.

Panel meeting: June 13, 2018

Patricia Parker, PhD (Chair) Memorial Sloan Kettering Cancer Center
New York, NY
Maru Barrera, PhD The Hospital for Sick Children
Toronto, ON
S. Nicole Culos-Reed, PhD  University of Calgary
Calgary, AB
Bruno Gagnon, PhD Laval University
Quebec, QC 
Karen Kopciuk, PhD Alberta Health Services
Edmonton, AB
Deborah Mayer, PhD  University of North Carolina
Chapel Hill, NC 
Jennifer O'Loughlin, PhD University of Montreal
Montreal, QC
Brenda Sabo, PhD Dalhousie University
Halifax, NS
Jennifer Stinson, PhD The Hospital for Sick Children
Toronto, ON 
Alice Wei, MD Princess Margaret Cancer Centre - UHN
Toronto, ON
Brita Danielson, MD (Scientific Officer) Cross Cancer Institute (Alberta Health Services)
Edmonton, AB
Lynn Gauthier, PhD (Scientific Officer) Laval University
Quebec, QC
Vanessa Steen (Community Representative) Canadian Cancer Society - Ontario

 

Impact Grant panel

LOI review teleconference: June 1, 2018

Panel meeting: November 7, 2018

Shoukat Dedhar, PhD (Co-Chair) BC Cancer Agency
Vancouver, BC
Lillian Sung, MD/PhD (Co-Chair) The Hospital for Sick Children
Toronto, ON
Stephane Angers, PhD University of Toronto
Toronto, ON
Rebecca Auer, MD Ottawa Hospital Research Institute
Ottawa, ON
Mick Bhatia, PhD McMaster University
Hamilton, ON
*Peter Black, MD University of British Columbia
Vancouver, BC
Darren Brenner, PhD University of Calgary
Calgary, AB
*Karen Emmons, PhD Harvard University
Boston, MA
Trang Hoang, PhD IRIC
Montreal, QC
Philip Kim, PhD
University of Toronto
Toronto, ON
Robert Kerbel, PhD Sunnybrook Research Institute
Toronto, ON 
Calum MacAulay, PhD BC Cancer Agency
Vancouver, BC 
Sylvain Meloche, PhD University of Montreal
Montreal, QC
*Anne-Marie Mes-Masson, PhD Centre de recherche du CHUM
Montreal, QC
*Karen Mossman, PhD McMaster University
Hamilton, ON
Claude Perreault, MD IRIC
Montreal, QC
*Janusz Rak, MD/PhD McGill University
Montreal, QC
James Rutka, MD/PhD The Hospital for Sick Children
Toronto, ON 
*Poul Sorensen, PhD BC Cancer Agency
Vancouver, BC
Bradly Wouters, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
*Jeffrey Wrana, PhD Mount Sinai Hospital
Toronto, ON
*Li Zhang, MD/PhD The Toronto General Hospital
Toronto, ON
*Camilla Zimmermann, MD/PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Jason Pole, PhD (Scientific Officer) Pediatric Oncology Group of Ontario
Toronto, ON
Sheila Singh, PhD (Scientific Officer)
McMaster University
Hamilton, ON 
Valerie Gauvin (Community Representative)
Canadian Cancer Society - BC/Yukon
Joel Finlay (Community Representative)
Canadian Cancer Society - BC/Yukon 

Prevention Innovation Grant panel

Panel meeting: October 5, 2017

Christine Friedenreich, PhD (Chair)  Alberta Health Services
Calgary, AB
Michael Chaiton, PhD  University of Toronto
Toronto, ON
Andrea Cherrington, MD University of Alabama at Birmingham
Birmingham, AL
Sean Cleary, MD Mayo Clinic
Rochester, MN
Hugh Davies, PhD University of British Columbia
Vancouver, BC 
Emmanuel Guindon, PhD
McMaster University
Hamilton, ON
Julia Knight, PhD
Mount Sinai Hospital
Toronto, ON
Karen Kopciuk, PhD Alberta Health Services
Calgary, AB
Charles Matthews, PhD
National Cancer Institute
Bethesda, MD
Colleen McBride, PhD Emory University
Atlanta, GA
Lawrence Paszat, MD University of Toronto
Toronto, ON 
Mark Purdue, PhD National Cancer Institute
Bethesda, MD 
Nicolas Wentzensen, MD/PhD National Cancer Institute
Bethesda, MD 
Regina Ziegler, PhD National Cancer Institute
Bethesda, MD
Jennifer Brunet, PhD (Scientific Officer) University of Ottawa
Ottawa, ON
Gillian Hanley, PhD (Scientific Officer) University of British Columbia
Vancouver, BC 
Joel Finlay (Community Representative) Canadian Cancer Society - BC/Yukon
Elizabeth MacLeod (Community Representative) Canadian Cancer Society - Ontario

Quality of Life Grant panel

LOI review teleconference: September 12, 2017

Panel meeting: January 10, 2018

Jamie Studts, PhD (Chair) University of Kentucky
Lexington, KY
Natasha Leighl, MD (Chair) Princess Margaret Cancer Centre
Toronto, ON
Jessica Burris, PhD University of Kentucky
Lexington, KY
*Kristin Campbell, PhD University of British Columbia
Vancouver, BC
Anees Chagpar, MD Yale University
New Haven, CT
*Kelvin Chan, MD Sunnybrook Research Institute
Toronto, ON 
*Winson Cheung, PhD BC Cancer Agency
Vancouver, BC
Kristine Donovan, PhD/MBA  Moffitt Cancer Center and Research Institute
Tampa, FL
Wendy Duggleby, PhD University of Alberta
Edmonton, AB
David Eisenstat, MD University of Alberta
Edmonton, AB 
*Heidi Hamann, PhD University of Arizona
Tucson, AZ
Shelby Langer, PhD Arizona State University
Tucson, AZ 
Sophie Lebel, PhD
University of Ottawa
Ottawa, ON
*Christopher Longo, PhD McMaster University
Hamilton, ON
*Paul Nathan, MD
The Hospital for Sick Children
Toronto, ON
*Suzanne O'Neill, PhD
Georgetown University
Washington, DC
Tony Panzarella, MSc Princess Margaret Cancer Centre
Toronto, ON 
*Tara Schapmire, PhD
University of Louisville School of Medicine
Louisville, KY 
Allen Sherman, PhD University of Arkansas for Medical Sciences
Little Rock, AR
Sumit Gupta, MD/PhD (Scientific Officer)
The Hospital for Sick Children
Toronto, ON
Alexander Louie, MD (Scientific Officer)
Lawson Health Research Institute
London, ON 
Scott Johnson (Community Representative) Canadian Cancer Society - Alberta/NWT
Cindy Vinall (Community Representative) Canadian Cancer Society - Ontario 

Knowledge to Action Grant panel

Panel meeting: September 15, 2017

David Chambers, PhD (Chair)  National Cancer Institute
Rockville, MD
Smita Banerjee, PhD Memorial Sloan-Kettering Cancer Center
New York, NY 
Carole Estabrooks, RN/PhD University of Alberta
Edmonton, AB
Anna Gagliardi, PhD University Health Network
Toronto, ON 
Monika Krzyzanowska, MD Princess Margaret Cancer Centre – UHN
Toronto, ON
France Légaré, MD/PhD Laval University
Quebec City, QC
Martine Puts, RN/PhD University of Toronto
Toronto, ON
Brenda Sabo, RN/PhD Dalhousie University
Halifax, NS
Janet Squires, RN/PhD University of Ottawa
Ottawa, ON
Marko Simunovic, MD McMaster University
Hamilton, ON
Robin Urquhart, PhD Dalhousie University
Halifax, NS 
Jessie-Lee McIsaac, PhD (Scientific Officer) Dalhousie University
Halifax, NS
Stephen Ng (Community Representative) Canadian Cancer Society - BC/Yukon Division

CCS-Quebec Division/Mont Gabriel Summit Research Fund (Cole Foundation) Grant panel

The Canadian Cancer Society Research Institute is pleased to support the partnership between the CCS Quebec Division, and the Cole Foundation and its partners, to fund research grants in the area of pediatric and young adult leukemia and lymphoma research. The CCSRI will administer the competition on their behalf as per CCSRI processes. Details of the competition can be found here.

Panel meeting: June 5, 2017

Jason Berman, MD (Chair) Dalhousie University
Halifax, NS
Sarah Alexander, MD The Hospital for Sick Children
Toronto, ON
Harold Atkins, MD Ottawa Hospital Research Institute
Ottawa, ON
Jeanette Boudreau, PhD
Dalhousie University
Halifax, NS
Todd Druley, MD/PhD Washington University in St. Louis
Saint Louis, MO
Xiaoyan Jiang, MD/PhD BC Cancer Agency
Vancouver, BC
Donna Johnston, PhD Children's Hospital of Eastern Ontario
Ottawa, ON 
Mark Minden, MD/PhD Princess Margaret Cancer Centre – UHN
Toronto, ON
Aaron Schimmer, MD/PhD Princess Margaret Cancer Centre – UHN
Toronto, ON
Steven Chan, MD/PhD (Scientific Officer) University Health Network
Toronto, ON

Breast Cancer Research Grant panels

Panel I - Fundamental laboratory and pre-clinical research

Fundamental laboratory and pre-clinical investigations addressing biology of breast cancer, etiology, prevention, early detection, diagnosis, prognosis, treatment (discovery and development), and development and characterization of model systems.

LOI Review meeting: October 13, 2016

Full Application Review meeting: February 27 & 28, 2017 

Jonathan Bramson, PhD (Chair) McMaster University
Hamilton, ON
Paola Marignani, PhD (Vice Chair)
Dalhousie University
Halifax, NS
Tommy Alain, PhD* Children's Hospital of Eastern Ontario
Ottawa, ON
Nicolas Bisson, PhD
Université Laval
Québec, QC
Ann Dorward, PhD
Memorial University of Newfoundland
St. John's, NL 
Humphrey Fonge, PhD*
University of Saskatchewan
Saskatoon, SK
Leonard Foster, PhD*
University of British Columbia
Vancouver, BC
Mitsuru Futakuchi, PhD*
Nagoya City University
Nagoya, Japan
Louis Gendron, PhD*
Université de Sherbrooke
Sherbrooke, QC
Ing Swie Goping, PhD  University of Alberta
Edmonton, AB 
Kensuke Hirasawa, PhD  Memorial University of Newfoundland
St. John’s, NL 
Nagarajan Kannan, PhD  Mayo Clinic
Rochester, MN 
Thomas Klonisch, PhD  The University of Manitoba
Winnipeg, MB 
Ujendra Kumar, PhD  University of British Columbia
Vancouver, BC  
Wan Lam, PhD*  BC Cancer Agency
Vancouver, BC 
James Lim, PhD*  University of British Columbia
Vancouver, BC
Julian Lum, PhD  BC Cancer Agency
Victoria, BC 
Anthony Magliocco, MD*  L. Lee Moffitt Cancer Centre & Research Institute
Tampa, FL 
Brian Marples, PhD*  University of Miami Miller School of Medicine
Miami, FL 
Luke McCaffrey, PhD  McGill University
Montreal, QC 
David Murray, PhD  University of Alberta
Edmonton, AB 
Neil O’Brien, PhD*  University of California, Los Angeles
Los Angeles, CA 
Catherine Pallen, PhD*  University of British Columbia
Vancouver, BC 
Lawrence Pfeffer, PhD*  The University of Tennessee
Memphis, TN 
Matthew Sikora, PhD  University of Colorado
Denver, CO 
John Spinelli, PhD*  BC Cancer Agency
Vancouver, BC 
Catherine Too, PhD*  Dalhousie University
Halifax, NS 
Alan Underhill, PhD*  University of Alberta
Edmonton, AB 
Nelson Wong, PhD  BC Cancer Agency
Vancouver, BC 
Yuliang Wu, PhD*  University of Saskatchewan
Saskatoon, SK 
Donald T. Yapp, PhD*  BC Cancer Agency
Vancouver, BC 
Sheila Singh, MD/PhD (External)  McMaster University
Hamilton, ON 
Lindsay DeVorkin, PhD (Scientific Officer)  BC Cancer Agency
Victoria, BC 
* denotes reviewers who participated in the LOI Review Process only

 

Panel II - Clinical, psychosocial, and evaluative research

Clinical projects and evaluative research addressing etiology, prevention, early detection, diagnosis, prognosis, treatment (clinical applications), evaluation of delivery methods and interventions, as well as projects addressing psychosocial issues, supportive care, survivorship, quality of life, behavioural research, cancer control, health systems and outcomes research.

LOI Review meeting: October 14, 2016

Full Application Review meeting: March 1, 2017 

Stephen Chia, MD (Co-Chair) BC Cancer Agency
Vancouver, BC
Craig Earle, MD (Co-Chair)
Sunnybrook Health Sciences Centre
Toronto, ON
Samuel Aparicio, PhD BC Cancer Agency
Vancouver, BC
Deanna Attai, MD
University of California Los Angeles
Los Angeles, CA
Tavis Campbell, PhD*
University of Calgary
Calgary, AB 
Karen Gelmon, MD
BC Cancer Agency
Vancouver, BC
Esther Green*
Canadian Partnership Against Cancer
Toronto, ON
Lee Jones, PhD
Memorial Sloan Kettering Cancer Center
New York, NY
Steven Latosinsky, MD
Western University
London, ON
Yolanda Madarnas, MD* Kingston General Hospital
Kingston, ON
Carole Mayer, PhD*  Northeast Cancer Centre
Sudbury, ON 
Alan Nichol, MD* BC Cancer Agency
Vancouver, BC 
Susan Peterson, PhD The University of Texas MD Anderson Cancer Center
Houston, TX 
Kasmintan Schrader, MD, PhD University of British Columbia
Vancouver, BC  
Kristin L. Schreiber, MD, PhD* Brigham and Women’s Hospital
Boston, MA 
Abigail Silva, PhD*  Loyola University Chicago
Chicago, IL 
Savitri Singh-Carlson, PhD  UT Health Science Center at San Antonio
San Antonio, TX 
Ted Vandenberg, MD*  London Health Sciences Centre
London, ON 
Rebecca Auer, MD (External)  The Ottawa Hospital
Ottawa, ON 
Christine Brezden-Masley, MD (External)  St. Michael’s Hospital
Toronto, ON 
Jay Harris, MD (External)  Harvard Medical School
Boston, MA 
Andrew Karellas, PhD (External)  University of Arizona
Tuscon, AZ 
Kara Laing, MD (External)  Memorial University of Newfoundland
St. John’s, NL 
Nelson Leong, MD (Scientific Officer)  Saskatchewan Cancer Agency
Regina, SK 
* denotes reviewers who participated in the LOI Review Process only

Last modified on: October 9, 2018